Related Experiment Video
Updated: Jun 19, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Use of Rituximab in the Management of a Nasopharyngeal Fibrosing Inflammatory Pseudotumor
Erika Hazan1, Samuel Bellavance2, Philippe Lavigne2
1Faculty of Medicine Université de Montréal Montreal Quebec Canada.
Abstract:
Fibrosing inflammatory pseudotumor (FIP) of the nasopharynx can mimic malignancy and IgG4-related disease (IgG4-RD), complicating diagnosis. This corticosteroid-dependent case responded well to rituximab despite not meeting IgG4-RD criteria. This highlights the diagnostic challenges and suggests rituximab as a potential steroid-sparing treatment for FIP.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Respiratory Syncytial Virus Disease

